Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors

Eric HattererLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, SwitzerlandCorrespondence[email protected]

Xavier ChauchetLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Françoise RichardLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Leticia BarbaLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Valéry MoineLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Laurence ChatelLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Lucile BroyerLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Guillemette PontiniLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Tereza BautzovaLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Flora JuanLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Sebastien CalloudLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Nicolas BossonLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Maud CharretonLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Krzysztof MasternakLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Vanessa BuatoisLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Limin ShangLight Chain Bioscience, Novimmune S.A., Plan-les-Ouates, Switzerland

Your download is now in progress and you may close this window